NCT05468125

Brief Summary

Cesarean Section (CS) is a common obstetric surgery that can be performed by both general or regional anaesthetic techniques. Hypotension is the most common complication of spinal anaesthesia, its incidence varying from 70% to 80 %, if severe, it can result in serious perinatal adverse outcomes, such as maternal nausea and vomiting, fetal acidosis and may be an important contributory factor for maternal death related to regional anaesthesia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
11 days until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2022

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 15, 2022

Status Verified

November 1, 2022

Enrollment Period

4 months

First QC Date

July 19, 2022

Last Update Submit

November 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • consumption of ephedrine

    The total consumption of ephedrine used to manage the spinal induced hypotension with CS

    immediately at the end of the surgery

Secondary Outcomes (2)

  • consumption of atropine

    immediately at the end of the surgery

  • postspinal hypotension

    immediately at the end of the surgery

Study Arms (2)

care bundle

ACTIVE COMPARATOR

will be subjected to a bundle of care of four elements

Procedure: guidance

best-evidenced practice

ACTIVE COMPARATOR

will be guided according to the best-evidenced performance consisting of three elements

Procedure: guidance

Interventions

guidancePROCEDURE

either follow the care bundle or the best evidence practice

best-evidenced practicecare bundle

Eligibility Criteria

Age21 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age more than 21 years old and less than 40 years.
  • Patients are ASA I (American Society of Anesthesiology physical status Grade I) = (normal healthy patients) or ASA II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations).
  • None laboring, at term with singleton uncomplicated pregnancies.
  • Delivery under spinal anesthesia, with height 150 to 180 cm
  • Body mass index of at most 40 kg/m2.

You may not qualify if:

  • Parturient with peri-partum disorders as DM, HTN, cardiac diseases, bronchial asthma or bleeding disorders
  • Obesity: BMI \>40
  • Any known allergy to local anesthetic drugs or ondansetron.
  • Apparent anatomical abnormalities or infections in the back region.
  • Bleeding disorders e.g., thrombocytopenia, high INR, high PT in the chronic liver or impaired kidney).
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal University

Ismailia, 2685, Egypt

Location

MeSH Terms

Conditions

Hypotension

Interventions

Counseling

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Abdelrhman Alshawadfy

    Suez Canal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
patients will be randomly allocated by a computer software program (www. Randmizer.org) and allocation sequence will be done by opaque closed envelope. Data will be collected by a separate anesthesiologist not sharing in the study and blinded to the technique being used.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and intensive care

Study Record Dates

First Submitted

July 19, 2022

First Posted

July 21, 2022

Study Start

August 1, 2022

Primary Completion

November 20, 2022

Study Completion

December 1, 2022

Last Updated

November 15, 2022

Record last verified: 2022-11

Locations